Richard G Vincent's Net Worth

$604 Thousand

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Richard G Vincent?

Richard G Vincent does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sorrento Therapeutics, Inc., Oncternal Therapeutics, Inc., and WOMEN FIRST HEALTHCARE INC.

SEC CIK

Richard G Vincent's CIK is 0001269341

Past Insider Trading and Trends

2022 was Richard G Vincent's most active year for acquiring shares with 12 total transactions. Richard G Vincent's most active month to acquire stocks was the month of September. 2023 was Richard G Vincent's most active year for disposing of shares, totalling 8 transactions. Richard G Vincent's most active month to dispose stocks was the month of September. 2003 saw Richard G Vincent paying a total of $132,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2023 Richard G Vincent cashed out on 749,946 shares for a total of $7,061.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.03

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 7
Form 4
—
0
—
—
0
Oct 29
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Sep 22
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Feb 5
Form 3
—
0
—
—
0
No matching records found

Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47

Chief Financial Officer

Richard G Vincent owns 140,922 units of Common Stock which is worth $629,921.34. From 2019 to 2024 Richard G Vincent acquired a total of 163,120 shares in Oncternal Therapeutics, Inc. at a cost of $37,796.38, Richard also disposed a total of 20,365 shares of Oncternal Therapeutics, Inc. equalling to $11,460.81.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 14
Form 4
-5.92%
-8.87K
$0.50
-$4,399.41
140.92K
Jan 3
Form 4
—
0
—
—
0
Oct 2
Form 4
-4.51%
-7.07K
$0.36
-$2,544.84
149.79K
Jul 3
Form 4
+23.65%
30K
$0.30
$8,961.00
156.86K
Apr 13
Form 4
—
0
—
—
0
Feb 21
Form 4
-3.37%
-4.43K
$1.02
-$4,516.56
126.86K
Jan 3
Form 4
+48.92%
43.13K
—
—
131.29K
Jul 28
Form 4
+6.01%
5K
$1.44
$7,210.38
88.16K
Mar 24 - Mar 28
Form 4
+17.69%
12.5K
$1.73
$21,625.00
83.16K
Jan 27 - Jan 28
Form 4
—
0
—
—
0
Jan 20
Form 4
+73.21%
29.87K
—
—
70.66K
Jan 3
Form 4
—
0
—
—
0
Feb 11
Form 4/A
—
0
—
—
0
Mar 17
Form 4/A
—
0
—
—
0
Sep 12
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Sep 12
Form 4
∞
48.99K
—
—
47.15K
Jun 7
Form 3
—
0
—
—
0
No matching records found

WOMEN FIRST HEALTHCARE INC No price found

VP, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 16
Form 3
—
0
—
—
0
No matching records found